GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adial Pharmaceuticals Inc (NAS:ADILW) » Definitions » Short Interest

Adial Pharmaceuticals (Adial Pharmaceuticals) Short Interest


View and export this data going back to 2018. Start your Free Trial

What is Adial Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Adial Pharmaceuticals's Short Interest

For the Biotechnology subindustry, Adial Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adial Pharmaceuticals's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adial Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Adial Pharmaceuticals's Short Interest falls into.



Adial Pharmaceuticals (Adial Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1180 Seminole Trail, Suite 495, Charlottesville, VA, USA, 22901
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Adial Pharmaceuticals (Adial Pharmaceuticals) Headlines